Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment.

Quantifying the physical disease burden attributable to schizophrenia provides a means of capturing the substantial excess mortality associated with this disorder within the GBD framework, contributing to an important evidence base for healthcare planning and practice.